·   Log in

Archive for May 6th, 2009

S&P’s top ten promising drugs of 2009-2010

Wednesday, May 6, 2009 20:23

  Denosumab, Brilinta, Effient & Afinitor among S&P list of 10 most promising drugs

This was posted under category: Pharma  |  Read Full Story  |  0 Comments

Ranbaxy’s malaria combination drug in last leg of human studies

Wednesday, May 6, 2009 19:37

  The combination pill from Ranbaxy uses arterolane and piperaquine to fight falciparum malaria.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with: ,

Hetero bags India’s one-million-dose oseltamivir order even as Strides joins fray

Wednesday, May 6, 2009 19:19

Leading oseltamivir makers like Cipla or Ranbaxy are yet to get the health ministry’s call.

This was posted under category: Industry, Pharma  |  Read Full Story  |  1 Comment

Avastin (bevacizumab) FDA approval for brain cancer treatment in US

Wednesday, May 6, 2009 12:23

  Avastin to treat most deadly form of brain cancer gets quick approval in US

This was posted under category: Legal  |  Read Full Story  |  0 Comments
Tagged with: , ,

Sun Pharma subsidiary Caraco asked to withdraw metformin pills in US

Wednesday, May 6, 2009 9:07

  Caraco Pharmaceutical Laboratories, the US subsidiary of Mumbai-based Sun Pharmaceuticals Industries, has been asked to withdraw many batches of its generic metformin hydrochloride tablets used for treating diabetes.

This was posted under category: Legal  |  Read Full Story  |  0 Comments
Tagged with: , ,

Cipla’s generic HIV drug tenofovir receives USFDA approval

Wednesday, May 6, 2009 8:45

  India's generic major Cipla has received tentative approval for HIV drug tenofovir disoproxil fumarate tablets, 300 mg, from United States Food and Drug Administration (USFDA)Tenofovir disoproxil fumarate tablets are indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.

This was posted under category: Legal  |  Read Full Story  |  3 Comments
Tagged with: , , , ,